209 related articles for article (PubMed ID: 23300021)
1. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic serum tocopherol levels and the risk of non-hodgkin lymphoma: the multiethnic cohort.
Morimoto Y; Ollberding NJ; Cooney RV; Wilkens LR; Franke AA; Le Marchand L; Goodman MT; Hernandez BY; Kolonel LN; Maskarinec G
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2075-83. PubMed ID: 24045922
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
[TBL] [Abstract][Full Text] [Related]
5. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
Saberi Hosnijeh F; Krop EJ; Scoccianti C; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Nawroly N; Portengen L; Linseisen J; Vineis P; Vermeulen R
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1577-84. PubMed ID: 20501772
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic circulating carotenoid levels and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort.
Ollberding NJ; Maskarinec G; Conroy SM; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Le Marchand L; Goodman MT; Hernandez BY; Henderson BE; Kolonel LN
Blood; 2012 Jun; 119(24):5817-23. PubMed ID: 22550343
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
9. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.
Morimoto Y; Conroy SM; Ollberding NJ; Henning SM; Franke AA; Wilkens LR; Goodman MT; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Maskarinec G
Cancer Causes Control; 2012 Oct; 23(10):1693-703. PubMed ID: 22907421
[TBL] [Abstract][Full Text] [Related]
11. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.
Garcia JM; Splenser AE; Kramer J; Alsarraj A; Fitzgerald S; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):229-238.e3. PubMed ID: 23954649
[TBL] [Abstract][Full Text] [Related]
12. The Association of Pre-diagnostic Inflammatory Markers and Adipokines and the Risk of Non-Hodgkin Lymphoma Development in Egypt.
El Demerdash DM; Tawfik NM; Elazab R; El Sissy MH
Indian J Hematol Blood Transfus; 2021 Jan; 37(1):76-81. PubMed ID: 33707838
[TBL] [Abstract][Full Text] [Related]
13. Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study.
Kathpalia M; Mishra P; Majid A; Khan MA; Sharma A; Bhurani D; Nidhi
J Neuroimmunol; 2024 Jul; 392():578372. PubMed ID: 38788317
[TBL] [Abstract][Full Text] [Related]
14. Circulating inflammation markers and prospective risk for lung cancer.
Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of some inflammatory markers in patients with lymphoma.
Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
[No Abstract] [Full Text] [Related]
16. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study.
Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
Cancer Causes Control; 2014 Nov; 25(11):1449-59. PubMed ID: 25070667
[TBL] [Abstract][Full Text] [Related]
17. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma.
Bertrand KA; Giovannucci E; Zhang SM; Laden F; Rosner B; Birmann BM
Cancer Prev Res (Phila); 2013 Aug; 6(8):864-73. PubMed ID: 23803416
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study.
Petridou ET; Sergentanis TN; Dessypris N; Vlachantoni IT; Tseleni-Balafouta S; Pourtsidis A; Moschovi M; Polychronopoulou S; Athanasiadou-Piperopoulou F; Kalmanti M; Mantzoros CS
J Clin Oncol; 2009 Oct; 27(30):5049-55. PubMed ID: 19738128
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.
Purdue MP; Hofmann JN; Kemp TJ; Chaturvedi AK; Lan Q; Park JH; Pfeiffer RM; Hildesheim A; Pinto LA; Rothman N
Blood; 2013 Aug; 122(6):951-7. PubMed ID: 23814017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
